It provides a balanced way to enjoy a hearty protein source and is ideal for those following a GLP-1 eating pattern
With clinical trials ongoing, phase 3 results arrive in 2026, guiding future treatment guidelines and potentially FDA approval
These findings highlight the importance of maintaining continuous GLP-1 treatment to sustain cardiovascular benefits and indicate that strategies to reduce treatment discontinuity should be developed to maximize the cardioprotective effects of GLP-1s
Finding an alternative to GLP-1s for weight loss If GLP-1 medications aren't right for you, here are a few other options to consider: Lifestyle or habit-building apps can be highly effective, especially if they include tracking capabilities and professional or clinical guidance
doi: 10.1016/s0026-0495(96)90192-4 33 KongM-FKingPMacdonaldIAStubbsTAPerkinsACBlackshawPEet al
These medications are not recommended by NICE, MHRA, or EMA for rheumatoid arthritis management